Skip to the page

Data / Drug companies / Interquim, S.A.

Interquim, S.A.: 36 products in the FDA NDC directory, labeler code 64552

Interquim, S.A. (labeler code 64552) lists 36 products in the FDA National Drug Code Directory. By type: 36 bulk ingredients. Its main marketing category is bulk ingredients. The newest product started marketing on January 1, 2023.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
64552
Products in commercial distribution
36
Packages
36
Finished drugs by generic name
0
Prescription products
0
Over the counter products
0
Started marketing in the last 12 months
0
Earliest marketing start
December 30, 1982
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Bulk ingredients36100%

Products by type

TypeProductsShare
Bulk ingredients36100%

Dosage forms

Dosage formProductsShare
Powder3597.2%
Liquid12.8%

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Tapinarof64552-4104PowderBulk ingredientsJanuary 1, 2023
Edaravone64552-4098PowderBulk ingredientsMay 5, 2017
Ozenoxacin64552-4029PowderBulk ingredientsDecember 31, 2016
Aripiprazole lauroxil64552-4079PowderBulk ingredientsOctober 5, 2015
Ferric carboxymaltose64552-4070PowderBulk ingredientsJuly 25, 2013
Aripiprazole monohydrate64552-4085PowderBulk ingredientsFebruary 28, 2013
Aripiprazole monohydrate64552-4085PowderBulk ingredientsFebruary 28, 2013
Aripiprazole monohydrate64552-4073PowderBulk ingredientsFebruary 28, 2013
Roflumilast64552-4096PowderBulk ingredientsFebruary 28, 2011
Roflumilast64552-4067PowderBulk ingredientsFebruary 28, 2011
Roflumilast64552-4053PowderBulk ingredientsFebruary 28, 2011
Paliperidone palmitate64552-4076PowderBulk ingredientsJuly 31, 2009
Paliperidone palmitate64552-4076PowderBulk ingredientsJuly 31, 2009
Paliperidone palmitate64552-4076PowderBulk ingredientsJuly 31, 2009
Paliperidone palmitate64552-4076PowderBulk ingredientsJuly 31, 2009
Paliperidone palmitate64552-4066PowderBulk ingredientsJuly 31, 2009
Paliperidone palmitate64552-4063PowderBulk ingredientsJuly 31, 2009
Paliperidone palmitate64552-4063PowderBulk ingredientsJuly 31, 2009
Paliperidone palmitate64552-4063PowderBulk ingredientsJuly 31, 2009
Paliperidone palmitate64552-4063PowderBulk ingredientsJuly 31, 2009
Paliperidone palmitate64552-4063PowderBulk ingredientsJuly 31, 2009
Paliperidone palmitate64552-4063PowderBulk ingredientsJuly 31, 2009
Paliperidone palmitate64552-4037PowderBulk ingredientsJuly 31, 2009
Rotigotine64552-4097PowderBulk ingredientsMay 9, 2007
Ragagiline tartrate64552-4044PowderBulk ingredientsMay 16, 2006

Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.